Laura K. Ferris
University of North Carolina at Chapel Hill(US)University of Pittsburgh(US)
Publications by Year
Research Areas
Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases, Pharmaceutical studies and practices, Asthma and respiratory diseases, Cutaneous Melanoma Detection and Management
Most-Cited Works
- → BAP1 regulates IP3R3-mediated Ca2+ flux to mitochondria suppressing cell transformation(2017)396 cited
- → Anti–IL-23A mAb BI 655066 for treatment of moderate-to-severe psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose, randomized, double-blind, placebo-controlled trial(2015)248 cited
- → A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial(2019)168 cited
- → Short- and long-term safety outcomes with ixekizumab from 7 clinical trials in psoriasis: Etanercept comparisons and integrated data(2016)130 cited
- → COVID-19 vaccine safety and efficacy in patients with immune-mediated inflammatory disease: Review of available evidence(2021)117 cited
- → Mutations in the human SC4MOL gene encoding a methyl sterol oxidase cause psoriasiform dermatitis, microcephaly, and developmental delay(2011)113 cited